Mercaptopurine and Depression - a phase IV clinical study of FDA data
Depression is found among people who take Mercaptopurine, especially for people who are female, 10-19 old, have been taking the drug for 2 - 5 years.
The phase IV clinical study analyzes which people take Mercaptopurine and have Depression. It is created by eHealthMe based on reports of 17,723 people who have side effects when taking Mercaptopurine from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.
With medical big data and AI algorithms, eHealthMe enables everyone to run phase IV clinical trial to detect adverse drug outcomes and monitor effectiveness. Our original studies have been referenced on 600+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Most recently, phase IV clinial trails for COVID 19 vaccines have been added, check here.
17,723 people reported to have side effects when taking Mercaptopurine.
Among them, 111 people (0.63%) have Depression.
What is Mercaptopurine?
Mercaptopurine has active ingredients of mercaptopurine. It is often used in crohn's disease. eHealthMe is studying from 17,982 Mercaptopurine users for its effectiveness, alternative drugs and more.
What is Depression?
Depression is found to be associated with 3,817 drugs and 3,845 conditions by eHealthMe.
Number of Mercaptopurine and Depression reports submitted per year:
Time on Mercaptopurine when people have Depression *:
Gender of people who have Depression when taking Mercaptopurine*:
Age of people who have Depression when taking Mercaptopurine *:
Common drugs people take besides Mercaptopurine *:
Common side effects people have besides Depression *:
Common conditions people have *:
* Approximation only. Some reports may have incomplete information.
Do you take Mercaptopurine and have Depression?Check whether Depression is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Related publications that referenced our studies
- Pang, T., & Gudi, A., "Chest pain following the use of fluvoxamine in depression", Proceedings of Singapore Healthcare, 2018 Jan .
Alternative drugs to, pros and cons of Mercaptopurine:
- Mercaptopurine (17,982 reports)
Depression treatments and more:
- Depression (563,426 reports)
COVID vaccines that are related to Depression:
- Depression in Moderna COVID Vaccine
- Depression in Pfizer BioNTech Covid Vaccine
- Depression in Johnson and Johnson Covid Vaccine
How severe was Depression and when was it recovered:
Expand to all the drugs that have ingredients of mercaptopurine:
- Depression and drugs with ingredients of mercaptopurine (112 reports)
Common drugs associated with Depression:
All the drugs that are associated with Depression:
- Depression (3,817 drugs)
Common conditions associated with Depression:
All the conditions that are associated with Depression:
- Depression (3,845 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on mercaptopurine (the active ingredients of Mercaptopurine) and Mercaptopurine (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Indapamide and International Normalised Ratio Decreased - a second ago
- Delzicol and Crestor drug interaction - 2 seconds ago
- Felodipine and Carbamazepine drug interaction - 3 seconds ago
- Catapres-Tts-1 and Apresoline drug interaction - 5 seconds ago
- High Blood Cholesterol and Tremor - 13 seconds ago